Receive the latest updates from Matrix Medical in real time to understand product information.

From August 21st to 23rd, the 2025 Medical Fair China (MFC) was held at the Suzhou International Expo Center. As an innovative medical enterprise nurtured and supported by the Yuhang District Government, Matrix Medical has received strong support from the district government for its appearance at the Suzhou exhibition. For a long time, Yuhang District has provided full chain support for enterprise development from resource empowerment of technology research and development to ecological cultivation of brand growth, and has always been a solid backing for us to deeply cultivate the field of medical innovation.

At this exhibition, Matrix Medical showcased its three major intervention field solutions and attracted high attention from domestic and foreign peers, experts, and procurement teams with its "Chinese original" technological breakthroughs and clinical value, becoming the focus of the vascular intervention field during the exhibition. On the first day of operation, the latest certified COLLEAL from Matrix Medical ® The debut of the hemostatic device immediately ignited the audience and became the focus of the exhibition, attracting widespread attention from domestic and foreign peers, partners, and clinical experts.

Representatives from overseas distributors and medical institutions from Europe, Southeast Asia, and other countries specifically visited the booth to discuss COLLEAL ® Conduct in-depth research on the innovative design principles and clinical application scenarios of hemostatic devices.

During the exhibition, Bao Liya, member of the Party Committee and Deputy Director of the Yuhang District Bureau of Commerce, visited the booth for research and guidance. She carefully examined the exhibits of the company, delved into the technical characteristics and market prospects of the latest certified products, fully recognized the breakthrough progress made by the company in the field of original medical products, and encouraged the team to continue to cultivate technological innovation, continuously improve core competitiveness, actively speak out on the exhibition platform, further expand brand influence, and inject new momentum into the high-quality development of the medical and health industry in Yuhang District.

Matrix Medical is deeply encouraged by this and will always focus on technological breakthroughs and achievement transformation, continuously enhance its core competitiveness, and contribute to the high-quality development of the medical and health industry in Yuhang District. At this MFC exhibition, Matrix Medical showcased COLLEAL ® The occluder hemostatic device is at the core, showcasing three major solutions covering nerve intervention, coronary intervention, and puncture pathway management, highlighting the product concept of "safety, precision, and innovation".

Three major solutions, leading the new era of interventional therapy

• Percutaneous Access Management

The latest certified hemostatic device in August breaks the monopoly of foreign technology and innovates the design of "balloon assisted collagen sponge" to achieve precise occlusion of 8F large caliber blood vessels, solving the pain point of residual risk of traditional hemostatic devices.

• Neurointervention

The intracranial balloon dilation catheter obtained registration certificate in 2024, providing a safer and more effective solution for neurointerventional surgery with its four core advantages of "safe dilation, easy delivery, long-lasting patency, and plaque remodeling". 

• Coronary Intervention

The coronary artery papillary balloon dilation catheter obtained its registration certificate in 2025. By using the "integrated molding process" to achieve zero risk of detachment and high burst pressure, a reliable solution is provided for complex coronary artery lesions.

Innovation brings together strength and inspires the future with wisdom. This MFC is not only a showcase for the achievements of the moment positive technology, but also an opportunity to expand the global cooperation network. In the future, Matrix Medical will continue to focus on original technology as its core driving force, deeply cultivate and refine in the field of vascular intervention, use Chinese original products to benefit global patients, and define the infinite possibilities of vascular intervention!